These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38922648)

  • 21. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.
    Silachamroon U; Krudsood S; Treeprasertsuk S; Wilairatana P; Chalearmrult K; Mint HY; Maneekan P; White NJ; Gourdeuk VR; Brittenham GM; Looareesuwan S
    Am J Trop Med Hyg; 2003 Jul; 69(1):14-8. PubMed ID: 12932090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
    Nekkab N; Lana R; Lacerda M; Obadia T; Siqueira A; Monteiro W; Villela D; Mueller I; White M
    PLoS Med; 2021 Apr; 18(4):e1003535. PubMed ID: 33891582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission.
    Morris U; Msellem MI; Mkali H; Islam A; Aydin-Schmidt B; Jovel I; Shija SJ; Khamis M; Ali SM; Hodzic L; Magnusson E; Poirot E; Bennett A; Sachs MC; Tarning J; Mårtensson A; Ali AS; Björkman A
    BMC Med; 2018 Dec; 16(1):215. PubMed ID: 30526588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.
    Malla P; Wang Z; Brashear A; Yang Z; Lo E; Baird K; Wang C; Cui L
    J Infect Dis; 2024 May; 229(5):1557-1564. PubMed ID: 38041857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
    Pukrittayakamee S; Imwong M; Chotivanich K; Singhasivanon P; Day NP; White NJ
    Am J Trop Med Hyg; 2010 Apr; 82(4):542-7. PubMed ID: 20348496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
    Krudsood S; Tangpukdee N; Wilairatana P; Phophak N; Baird JK; Brittenham GM; Looareesuwan S
    Am J Trop Med Hyg; 2008 May; 78(5):736-40. PubMed ID: 18458306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
    PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interventions for promoting patients' adherence to 14-day primaquine treatment in a highly malaria-endemic township in Myanmar: a qualitative study among key stakeholders.
    Win KM; Aung PL; Ring Z; Linn NYY; Kyaw MP; Nguitragool W; Cui L; Sattabongkot J; Lawpoolsri S
    Malar J; 2023 Oct; 22(1):302. PubMed ID: 37814267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
    IMPROV Study Group
    BMC Infect Dis; 2015 Dec; 15():558. PubMed ID: 26643116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial.
    Poespoprodjo JR; Burdam FH; Candrawati F; Ley B; Meagher N; Kenangalem E; Indrawanti R; Trianty L; Thriemer K; Price DJ; Simpson JA; Price RN
    Lancet Infect Dis; 2022 Mar; 22(3):367-376. PubMed ID: 34710363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the acceptability and feasibility of reactive drug administration for malaria elimination in a Plasmodium vivax predominant setting: a qualitative study in two provinces in Thailand.
    Suwannarong K; Cotter C; Ponlap T; Bubpa N; Thammasutti K; Chaiwan J; Finn TP; Kitchakarn S; Mårtensson A; Baltzell KA; Hsiang MS; Lertpiriyasuwat C; Sudathip P; Bennett A
    BMC Public Health; 2023 Jul; 23(1):1346. PubMed ID: 37438774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C; Rajapakse S; Fernando D
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India.
    Ahmad SS; Verma R; Commons RJ; Nitika ; Singh-Phulgenda S; Chhajed R; Bharti PK; Behera B; Naser SM; Pal SK; Ranjit PH; Baharia RK; Solanki B; Upadhyay KJ; Guerin PJ; Sharma A; Price RN; Rahi M; Thriemer K
    Trials; 2024 Feb; 25(1):154. PubMed ID: 38424577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Directly observed therapy with primaquine to reduce the recurrence rate of plasmodium vivax infection along the Thai-Myanmar border.
    Maneeboonyang W; Lawpoolsri S; Puangsa-Art S; Yimsamran S; Thanyavanich N; Wuthisen P; Prommongkol S; Chaimongkul W; Rukmanee P; Rukmanee N; Chavez IF; Buchachart K; Krudsood S; Singhasivanon P
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):9-18. PubMed ID: 21323159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.
    Nelwan EJ; Ekawati LL; Tjahjono B; Setiabudy R; Sutanto I; Chand K; Ekasari T; Djoko D; Basri H; Taylor WR; Duparc S; Subekti D; Elyazar I; Noviyanti R; Sudoyo H; Baird JK
    BMC Med; 2015 Dec; 13():294. PubMed ID: 26654101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
    Chu CS; Phyo AP; Lwin KM; Win HH; San T; Aung AA; Raksapraidee R; Carrara VI; Bancone G; Watson J; Moore KA; Wiladphaingern J; Proux S; Sriprawat K; Winterberg M; Cheah PY; Chue AL; Tarning J; Imwong M; Nosten F; White NJ
    Clin Infect Dis; 2018 Oct; 67(10):1543-1549. PubMed ID: 29889239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resolving the cause of recurrent Plasmodium vivax malaria probabilistically.
    Taylor AR; Watson JA; Chu CS; Puaprasert K; Duanguppama J; Day NPJ; Nosten F; Neafsey DE; Buckee CO; Imwong M; White NJ
    Nat Commun; 2019 Dec; 10(1):5595. PubMed ID: 31811128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Efficacy of Primaquine Treatment for Plasmodium vivax in Western Thailand.
    Longley RJ; Sripoorote P; Chobson P; Saeseu T; Sukasem C; Phuanukoonnon S; Nguitragool W; Mueller I; Sattabongkot J
    Am J Trop Med Hyg; 2016 Nov; 95(5):1086-1089. PubMed ID: 27601524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
    Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
    Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.